Publications and conferences
• Edmonds E, Hunt S, Hawkins D, Dinneen M, Francis N & Bunker CB. Clinical parameters in male genital lichen sclerosus: a case series of 329 patients. J Eur Acad Dermatol Venereol 2012;26:730-7.• Chapman A, Williams G, Soni N, Bunker CB. G-CSF in toxic epidermal necrolysis (TEN). Br J Dermatol 2010;162:860-5.
• Fearfield LA, Larkin JMG, Rowe A, A’Hern R, Fisher C, Francis N, MacKie R, McCann B, Gore ME & Bunker CB. Expression of p16, CD95, CD95L and HPA in relapsing and non-relapsing very thin melanoma. Br J Dermatol 2007;156:440-7.• Mallon E, Bunce M, Savoie H, Rowe A, Newson R, Gotch F & Bunker CB. HLA-C and guttate psoriasis. Br J Dermatol 2000;143:1177-1182.• Mallon E, Young D, Bunce M, Gotch FM, Easterbrook PJ, Newson R & Bunker CB HLA-Cw*0602 and HIV associated psoriasis. Br J Dermatol 1998;139:527-533.• Bunker CB, Newton JA, Kilborn J, Patel A, Conway GS, Jacobs HS, Greaves MW & Dowd PM. Most women with acne have polycystic ovaries. Br J Dermatol 1989;121:675-680.• Mallon E, Newson R & Bunker CB. HLA-Cw6 and the genetic predisposition to psoriasis: a meta analysis of serological studies. J Invest Dermatol 1999;113:693-5.• Rowe A, Mallon E, Rosenberger P, Barrett M, Walsh J & Bunker CB. Depletion of cutaneous peptidergic innervation in HIV-associated xerosis. J Invest Dermatol 1999;112:284-9.• Bull HA, Courtney PF, Bunker CB, Rustin MHA, Pearce FL & Dowd PM. Basophil mediator release in atopic dermatitis. J Invest Dermatol 1993;100:305-309.• Bunker CB, Foreman JC & Dowd PM. Digital vascular responses to histamine, compound 48/80 and calcitonin gene-related peptide in patients with Raynaud’s phenomenon. J Invest Dermatol 1991;96:314-317.• Bunker CB, Reavley C, O’Shaughnessey D & Dowd PM. Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud’s phenomenon. Lancet 1993; 342:80-82.• Bunker CB, Terenghi G, Springall DR, Polak JM & Dowd PM. Deficiency of calcitonin generelated peptide in Raynaud’s phenomenon. Lancet 1990;336:1530-33.• Bunker CB. Acne: a review of therapy. Drugs of Today 1988;24 229-234.• Morar N, Willis-Owen SA, Maurer T & Bunker CB. HIV associated psoriasis: pathogenesis, clinical features and management. Lancet Inf Dis 2010;10:470-478.• Meys R Gotch FM & Bunker CB. Human papillomavirus in the HAART era of HIV: an immune reconstitution associated disease (IRAD)? Br J Dermatol 2010;162:6-11.• Singh S, Kaye S, Gore ME, McClure MO, Bunker CB. The role of human endogenous retroviruses in melanoma. Br J Dermatol 2009;161:1225-1231.• Singh S & Bunker CB. Male genital dermatoses in old age. Age Ageing 2008;37:500-504• Porter WM & Bunker CB. The dysfunctional foreskin. Int J STD & AIDS 2001;12:216-20.• Bunker CB. CGRP, ET-1 and Raynaud’s phenomenon. Current Medical Literature: Rheumatology 1993;12: 87-89.• Bunker CB. Acne: a review of therapy. Drugs of Today 1988;24 229-234.• Bunker CB. Urine in the causation of male genital lichen sclerosus. Re: Kulkarni S et al. Lichen sclerosus of the male genitalia and urethra: surgical options and results in a multicenter international experience with 215 patients. Eur Urol 2009;55:945–956.• Bunker CB, Edmonds E, Hawkins D, Francis N & Dinneen M. Re: Pugliese et al. Lichen sclerosus: review of the literature and current recommendations for management. J Urol 2009;181:1802-3.• Singh S, Kaye S, Francis ND, Peston D, Gore ME, McClure MO & Bunker CB. Revisiting the past: utilising archival tissue for the detection and quantification of gene expression. Br J Dermatol 2009;160:885-6.• Burge S, Bunker C & Eedy D. Modernising Medical Careers. The Times 2007 (Mar 21).• Mallon E, Newson R & Bunker CB. HLA-Cw6 and the genetic predisposition to psoriasis: a meta-analysis of published serologic studies. J Invest Dermatol 1999;113:693-5.• Dowd PM, Bunker CB, Bull HA, Foreman JC, Terenghi G, Springall DR, & Polak JM. Raynaud’s phenomenon, calcitonin gene-related peptide, endothelin and cutaneous vasculature. Lancet 1990;336:1014.• Rowe A, Farrell A, Kazmi SH, & Bunker CB. Expression of inducible nitric oxide synthase in dermal microvasculature in psoriasis. Lancet 1994;344:1371.• Bunker CB, Whittaker S, Luzatto L, Gore ME, Rustin MHA, Smith NP & Levene GM. Indolent cutaneous prodrome of fatal HTLV-1 infection. Lancet 1990;335:426.• Bunker CB, Foreman JC, & Dowd PM. Calcitonin gene-related peptide and Raynaud’s phenomenon. Lancet 1990;335:239.• Bunker CB & Dowd PM. Topical minoxidil, scalp hair, and vasodilatation. Lancet 1987; i:1266• Bunker CB. Diseases and disorders of the male genitalia. In: Goldsmith LA. Katz SI, Gilchrest BA, Paller AS, Leffell DJ & Wolff K. Eds. Fitzpatrick’s Dermatology in General Medicine, 8th edition. McGraw Hill 2012, pp 852-877.• Calonje E, Neill S, Bunker C, Francis N, Chaux A & Cubilla AC. Diseases of the anogenital skin. In: McKee’s Pathology of the Skin. Eds Calonje E, Brenn T, Lazar A& McKee P. 4 th Edition. Elsevier Saunders. London. 2012 Chapter 12. 438-519; pp 452-456.• Bunker CB. Non-venereal penile dermatoses. In: Gupta S. & Kumar B. Eds. Sexually Transmitted Infections 2 nd edition. Elsevier, New Delhi, 2012; pp 703-727.• Edwards S & Bunker CB. Other conditions affecting the male genitalia. In: ABC of Sexually Transmitted Infections. Ed. Rogstad KE. Sixth Edition. Wiley-Blackwell 2011, pp 35-41.• Bunker CB. Dermatology. In: Medicine at a Glance 3e. Edited by Davey P. Wiley-Blackwell, Oxford, 2010.• Bunker CB & Neill S.A. The genital, perianal and umbilical regions. In: T.Burns, S. Breathnach, N.Cox and C. Griffiths, (eds.) Rook’s Textbook of Dermatology. 8th edition. Wiley-Blackwell, New York. 2010;71:1-102.• Bunker CB & Gotch F. HIV and AIDS. In: T.Burns, S. Breathnach, N.Cox and C. Griffiths, (eds.) Rook’s Textbook of Dermatology. 8th edition. Wiley-Blackwell, New York. 2010;35:1-47.• Bunker CB. Male Genital Dermatology. Fitzpatrick’s Dermatology in General Medicine, 7 th 6 edition. Wiley 2007.• Bunker CB. Chapter 51. Non-venereal penile dermatoses. In: Kumar B, Gupta S Eds. Sexually Transmitted Infections. Elsevier, New Delhi, 2005; pp 539-564.• Bunker CB. Dermatology. In: Medicine at a Glance 2e. Edited by Davey P. Blackwell Scientific Publications, Oxford, 2005.• Bunker CB & Staughton RCD. Genital inflammatory papules and nodules. In: Genital Dermatology. Edited by Edwards L. Saunders, Philadelphia, 2004.• Bunker CB. Skin Disease. In: Medicine 2e (Edited by Axford J, O’Callaghan J.) Blackwell Scientific Publications. Oxford, 2004.• Bunker CB & Neill SA. The Umbilicus, Perianal and Genital Regions. In: Textbook of Dermatology. 7th Edition. Oxford, Blackwells. 2004.• Bunker CB & Gotch F. HIV and AIDS. In: Textbook of Dermatology. 7th Edition. Oxford, Blackwells. 2004.• Agnew K, Gilchrest B & Bunker CB. Fast Facts-Skin Cancer. Health Press, London UK, 2005• Bunker CB. Male Genital Dermatology. Saunders, London, 2004.• Fearfield L, Stephenson A, Bunker CB, Thomas M & Gore M. Skin cancer and melanoma. In: Cancer in Primary Care. Eds Gore M. & Russell D. Martin Dunitz, London & New York, 2003.• Bunker CB & Staughton RCD. Dermatology. In: Chelsea & Westminster AIDS Care Handbook. Edited by Gazzard B. Mediscript, London, 2002• Bunker CB. Dermatology. In: Medicine at a Glance. Edited by Davey P. Blackwell Scientific Publications, Oxford, 2002• Bunker CB & Staughton RCD. Dermatology. In: Chelsea & Westminster AIDS Care Handbook. Edited by Gazzard B. Mediscript, London, 1999.• Bunker CB & Bridgett CK. Depression and the Skin. In: Depression and physical illness. Edited by Robertson MM. & Katona CLE. John Wiley & Sons, London,1997.• Bunker CB. Dermatological Problems in HIV Infection and AIDS. In: Medical Management of HIV and AIDS. Edited by Millar A. Springer-Verlag. Berlin, 1996; 162-189.• Bunker CB & Dowd PM. Raynaud’s phenomenon. In: Cutaneous Medicine and Surgery. Edited by Arndt et al.. Saunders, New York, 1996.• Bunker CB & Dowd PM. Skin Disease. In: Medicine. Edited by Axford J. Blackwell Scientific Publications, Oxford, 1996.• Male Genital Lichen Sclerosus-from dyspareunia to penis cancer, Urology Arena, Berne (2014)• HIV Dermatology in the Era of cART, Retired Fellows’ Society, Royal Society of Medicne, London (2014)• Toxic Epidermal Necrolysis, North London Academic Dermatology Meeting, London (2014)• HIV Dermatology in the Era of cARV Therapy, College of Podiatry Annual Conference, Bournemouth (2014)• Male Genital Lichen Sclerosus (Lichen Planus & Zoon’s balanitis), BASHH Genital Dermatology Course, London (2014)• Male Genital Lichen Sclerosus, European Academy of Dermatology & Venereology, Amsterdam (2014)• HIV and Skin Manifestations, European Academy of Dermatology & Venereology, Amsterdam (2014)• Melanoma and Non-melanoma Skin Cancer in HIV, World Congress on Cancer of the Skin, Edinburgh (2014)• HIV and Skin Manifestations, Eropean Academy of Dermatology & Venereology, Amsterdam (2014)• Melanoma and Non-melanoma Skin Cancer in HIV, World Congress on Cancer of the Skin, Edinburgh (2014)• The Aetiopathogenesis of Male Genital Lichen Sclerosus, Dowling Club, Moscow (2014)• Clinical and Research Agenda, British Association of Dermatologists (2014)• Toxic Epidermal Necrolysis, Baltic Association of Dermatovenereologists, Riga (2014)• Toxic Epidermal Necrolysis, Australasian College of Dermatologists, Melbourne (2014)• The Aetiopathogenesis of Male Genital Lichen Sclerosus, Genital Dermatology Symposium, Australasian College of Dermatologists, Melbourne (2014)• HIV Dermatology, Australasian College of Dermatologists, Melbourne (2014)• Selected Topics in Male Genital Dermatology, Registrar Training Day, Australasian College of Dermatologists, Melbourne (2014)• A Different Perspective: Male Genital Lichen Sclerosus, British Society for the Study of Vulval Disease, Glasgow (2014)• Crisis in Dermatology: Happy Birthday PCDS, Primary Care Dermatology Society, Kenilworth (2014)• Lichen Sclerosus in Men, Male Gential Dermatology and Oral Dermatology, University of Hertfordshire, Hatfield (2014)• HIV Dermatology post cART 2014, European Dermatology Forum, Bern• John Thornton Ingram Lecture, Royal College of Physicians (2001)
...
